Toward the relevance of platelet subpopulations for transfusion medicine

Frontiers in Medicine

Volumn 5, Issue FEB, 2018, Pages

  Handtke, Stefan ^a   Steil, Leif ^b   Greinacher, Andreas ^a   Thiele, Thomas ^a  

^a Institut fur Immunologie und Transfusionsmedizin   (Germany)

^b Interfakultäres Institut für Funktionelle Genomforschung   (Germany)

Author keywords

Platelet clearance; Platelet maturation; Platelet size; Platelet subpopulation; Platelet turnover

Indexed keywords

EID: 85049252055     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2018.00017     Document Type: Short Survey

References (111)

1. Mancuso ME, Santagostino E. Platelets: much more than bricks in a breached wall. Br J Haematol (2017) 178(2):209-19. doi:10.1111/bjh.14653
2. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood (2014) 123(18):2759-67. doi:10.1182/blood-2013-11-462432
3. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost (2011) 9(6):1097-107. doi:10.1111/j.1538-7836.2011.04264.x
4. Gros A, Ollivier V, Ho-Tin-Noe B. Platelets in inflammation: regulation of leukocyte activities and vascular repair. Front Immunol (2014) 5:678. doi:10.3389/fimmu.2014.00678
5. Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O. Platelets and infections-complex interactions with bacteria. Front Immunol (2015) 6:82. doi:10.3389/fimmu.2015.00082
6. McDonald TP, Odell TT Jr, Gosslee DG. Platelet size in relation to platelet age. Proc Soc Exp Biol Med (1964) 115:684-9. doi:10.3181/00379727-115-29006
7. Mezzano D, Hwang K, Catalano P, Aster RH. Evidence that platelet buoyant density, but not size, correlates with platelet age in man. Am J Hematol (1981) 11(1):61-76. doi:10.1002/ajh.2830110108
8. Thompson CB, Love DG, Quinn PG, Valeri CR. Platelet size does not correlate with platelet age. Blood (1983) 62(2):487-94
9. Agbani EO, Poole AW. Procoagulant platelets: generation, function and therapeutic targeting in thrombosis. Blood (2017) 130(20):2171-79. doi:10.1182/blood-2017-05-787259
10. Cognasse F, Sut C, Fromont E, Laradi S, Hamzeh-Cognasse H, Garraud O. Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model. Blood (2017) 130(11):1380-3. doi:10.1182/blood-2017-03-773945
11. Garraud O, Tariket S, Sut C, Haddad A, Aloui C, Chakroun T, et al. Transfusion as an inflammation hit: knowns and unknowns. Front Immunol (2016) 7:534. doi:10.3389/fimmu.2016.00534
12. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost (2010) 8(1):148-56. doi:10.1111/j.1538-7836.2009.03584.x
13. Schick UM, Jain D, Hodonsky CJ, Morrison JV, Davis JP, Brown L, et al. Genome-wide association study of platelet count identifies ancestry-specific loci in Hispanic/Latino Americans. Am J Hum Genet (2016) 98(2):229-42. doi:10.1016/j.ajhg.2015.12.003
14. Soranzo N, Rendon A, Gieger C, Jones CI, Watkins NA, Menzel S, et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood (2009) 113(16):3831-7. doi:10.1182/blood-2008-10-184234
15. Nurnberg ST, Rendon A, Smethurst PA, Paul DS, Voss K, Thon JN, et al. A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site. Blood (2012) 120(24):4859-68. doi:10.1182/blood-2012-01-401893
16. Shameer K, Denny JC, Ding K, Jouni H, Crosslin DR, de Andrade M, et al. A genome-and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects. Hum Genet (2014) 133(1):95-109. doi:10.1007/s00439-013-1355-7
17. Li J, Glessner JT, Zhang H, Hou C, Wei Z, Bradfield JP, et al. GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American children. Hum Mol Genet (2013) 22(7):1457-64. doi:10.1093/hmg/dds534
18. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G, et al. New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 480(7376):201-8. doi:10.1038/nature10659
19. De Gabriele G, Penington DG. Regulation of platelet production: "thrombopoietin". Br J Haematol (1967) 13(2):210-5. doi:10.1111/j.1365-2141.1967.tb08733.x
20. Levin J, Levin FC, Hull DF III, Penington DG. The effects of thrombopoietin on megakaryocyte-cfc, megakaryocytes, and thrombopoiesis: with studies of ploidy and platelet size. Blood (1982) 60(4):989-98
21. Harker LA, Roskos LK, Marzec UM, Carter RA, Cherry JK, Sundell B, et al. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood (2000) 95(8):2514-22
22. Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest (2005) 115(12):3348-54. doi:10.1172/JCI26891
23. Thon JN, Italiano JE. Platelet formation. Semin Hematol (2010) 47(3):220-6. doi:10.1053/j.seminhematol.2010.03.005
24. Dutting S, Gaits-Iacovoni F, Stegner D, Popp M, Antkowiak A, van Eeuwijk JMM, et al. A Cdc42/RhoA regulatory circuit downstream of glycoprotein Ib guides transendothelial platelet biogenesis. Nat Commun (2017) 8:15838. doi:10.1038/ncomms15838
25. Schwertz H, Koster S, Kahr WH, Michetti N, Kraemer BF, Weitz DA, et al. Anucleate platelets generate progeny. Blood (2010) 115(18):3801-9. doi:10.1182/blood-2009-08-239558
26. Larson MK, Watson SP. Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3. Blood (2006) 108(5):1509-14. doi:10.1182/blood-2005-11-011957
27. Thon JN, Macleod H, Begonja AJ, Zhu J, Lee KC, Mogilner A, et al. Microtubule and cortical forces determine platelet size during vascular platelet production. Nat Commun (2012) 3:852. doi:10.1038/ncomms1838
28. Stegner D, vanEeuwijk JMM, Angay O, Gorelashvili MG, Semeniak D, Pinnecker J, et al. Thrombopoiesis is spatially regulated by the bone marrow vasculature. Nat Commun (2017) 8(1):127. doi:10.1038/s41467-017-00201-7
29. Machlus KR, Thon JN, Italiano JE Jr. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol (2014) 165(2):227-36. doi:10.1111/bjh.12758
30. Lefrancais E, Ortiz-Munoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature (2017) 544(7648):105-9. doi:10.1038/nature21706
31. Kowata S, Isogai S, Murai K, Ito S, Tohyama K, Ema M, et al. Platelet demand modulates the type of intravascular protrusion of megakaryocytes in bone marrow. Thromb Haemost (2014) 112(4):743-56. doi:10.1160/TH14-02-0123
32. Nishimura S, Nagasaki M, Kunishima S, Sawaguchi A, Sakata A, Sakaguchi H, et al. IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol (2015) 209(3):453-66. doi:10.1083/jcb.201410052
33. Thiele T, Braune J, Dhople V, Hammer E, Scharf C, Greinacher A, et al. Proteomic profile of platelets during reconstitution of platelet counts after apheresis. Proteomics Clin Appl (2016) 10(8):831-8. doi:10.1002/prca.201500134
34. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size as a determinant of platelet function. J Lab Clin Med (1983) 101(2):205-13
35. Booyse FM, Rafelson ME Jr. Studies on human platelets. I. Synthesis of platelet protein in a cell-free system. Biochim Biophys Acta (1968) 166(3):689-97. doi:10.1016/0005-2787(68)90376-6
36. Karpatkin S. Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest (1969) 48(6):1073-82. doi:10.1172/JCI106063
37. Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest (1969) 48(6):1083-7. doi:10.1172/JCI106064
38. Karpatkin S, Strick N. Heterogeneity of human platelets. V. Differences in glycolytic and related enzymes with possible relation to platelet age. J Clin Invest (1972) 51(5):1235-43. doi:10.1172/JCI106918
39. Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol (1983) 53(3):503-11. doi:10.1111/j.1365-2141.1983.tb02052.x
40. Mezzano D, Aranda E, Foradori A. Comparative study of size, total protein, fibrinogen and 5-HT content of human and canine platelet density subpopulations. Thromb Haemost (1986) 56(3):288-92
41. Pereira J, Cretney C, Aster RH. Variation of class I HLA antigen expression among platelet density cohorts: a possible index of platelet age? Blood (1988) 71(2):516-9
42. Frojmovic M, Wong T. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. II. Platelet size-dependent subpopulations. Biophys J (1991) 59(4):828-37. doi:10.1016/S0006-3495(91)82295-0
43. Polanowska-Grabowska R, Raha S, Gear AR. Adhesion efficiency, platelet density and size. Br J Haematol (1992) 82(4):715-20. doi:10.1111/j.1365-2141.1992.tb06949.x
44. Opper C, Schrumpf E, Gear AR, Wesemann W. Involvement of guanylate cyclase and phosphodiesterases in the functional heterogeneity of human blood platelet subpopulations. Thromb Res (1995) 80(6):461-70. doi:10.1016/0049-3848(95)00201-4
45. Li BY, He SZ, Li WH. Heterogeneity of human platelet density subpopulations in aggregation, secretion of ATP, and cytosolic-free calcium concentration. Zhongguo Yao Li Xue Bao (1996) 17(2):152-5
46. Opper C, Schuessler G, Kuschel M, Clement HW, Gear AR, Hinsch E, et al. Analysis of GTP-binding proteins, phosphoproteins, and cytosolic calcium in functional heterogeneous human blood platelet subpopulations. Biochem Pharmacol (1997) 54(9):1027-35. doi:10.1016/S0006-2952(97)00317-1
47. Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis (2010) 30(3):251-62. doi:10.1007/s11239-010-0489-x
48. Brambilla M, Rossetti L, Zara C, Canzano P, Giesen PLA, Tremoli E, et al. Do methodological differences account for the current controversy on tissue factor expression in platelets? Platelets (2017):1-9. doi:10.1080/09537104.2017.1327653
49. Balduini CL, Noris P, Spedini P, Belletti S, Zambelli A, Da Prada GA. Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy. Br J Haematol (1999) 106(1):202-7. doi:10.1046/j.1365-2141.1999.01475.x
50. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 122(3):379-91. doi:10.1016/j.cell.2005.06.015
51. Frojmovic M, Wong T, van de Ven T. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. I. Methodology, theory and results for two distinct activators. Biophys J (1991) 59(4):815-27. doi:10.1016/S0006-3495(91)82294-9
52. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 203(11):2433-40. doi:10.1084/jem.20061302
53. Blajchman MA, Senyi AF, Hirsh J, Genton E, George JN. Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets. J Clin Invest (1981) 68(5):1289-94. doi:10.1172/JCI110375
54. Adly AA, Ragab IA, Ismail EA, Farahat MM. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets (2015) 26(7):645-50. doi:10.3109/09537104.2014.969220
55. Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, et al. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol (2005) 128(5):698-702. doi:10.1111/j.1365-2141.2004.05357.x
56. Ntaios G, Papadopoulos A, Chatzinikolaou A, Saouli Z, Karalazou P, Kaiafa G, et al. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Haematol (2008) 119(3):173-7. doi:10.1159/000135658
57. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis (1996) 7(2):157-61. doi:10.1097/00001721-199603000-00011
58. Freynhofer MK, Gruber SC, Grove EL, Weiss TW, Wojta J, Huber K. Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing. Thromb Haemost (2015) 114(3):459-68. doi:10.1160/TH15-02-0179
59. Castle V, Coates G, Kelton JG, Andrew M. 111In-oxine platelet survivals in thrombocytopenic infants. Blood (1987) 70(3):652-6
60. Lippi G. Genetic and nongenetic determinants of mean platelet volume. Blood (2016) 127(2):179-80. doi:10.1182/blood-2015-11-679852
61. Panova-Noeva M, Schulz A, Hermanns MI, Grossmann V, Pefani E, Spronk HM, et al. Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study. Blood (2016) 127(2):251-9. doi:10.1182/blood-2015-07-660308
62. Montoro-Garcia S, Schindewolf M, Stanford S, Larsen OH, Thiele T. The role of platelets in venous thromboembolism. Semin Thromb Hemost (2016) 42(3):242-51. doi:10.1055/s-0035-1570079
63. Freynhofer MK, Iliev L, Bruno V, Rohla M, Egger F, Weiss TW, et al. Platelet turnover predicts outcome after coronary intervention. Thromb Haemost (2017) 117(5):923-33. doi:10.1160/TH16-10-0785
64. Noris P, Melazzini F, Balduini CL. New roles for mean platelet volume measurement in the clinical practice? Platelets (2016) 27(7):607-12. doi:10.1080/09537104.2016.1224828
65. Eicher JD, Chami N, Kacprowski T, Nomura A, Chen MH, Yanek LR, et al. Platelet-related variants identified by exomechip meta-analysis in 157,293 individuals. Am J Hum Genet (2016) 99(1):40-55. doi:10.1016/j.ajhg.2016.05.005
66. Greinacher A, Pecci A, Kunishima S, Althaus K, Nurden P, Balduini CL, et al. Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders. J Thromb Haemost (2017) 15(7):1511-21. doi:10.1111/jth.13729
67. Ingram M, Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol (1969) 17(3):225-9. doi:10.1111/j.1365-2141.1969.tb01366.x
68. Fujii T, Shimomura T, Fujimoto TT, Kimura A, Fujimura K. A new approach to detect reticulated platelets stained with thiazole orange in thrombocytopenic patients. Thromb Res (2000) 97(6):431-40. doi:10.1016/S0049-3848(99)00182-6
69. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol (1995) 23(9):996-1001
70. Dale GL, Friese P, Hynes LA, Burstein SA. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood (1995) 85(7):1822-5
71. Angenieux C, Maitre B, Eckly A, Lanza F, Gachet C, de la Salle H. Time-dependent decay of mRNA and ribosomal RNA during platelet aging and its correlation with translation activity. PLoS One (2016) 11(1):e0148064. doi:10.1371/journal.pone.0148064
72. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood (1990) 75(1):116-21
73. Robinson M, MacHin S, Mackie I, Harrison P. In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. Br J Haematol (2000) 108(4):859-64. doi:10.1046/j.1365-2141.2000.01939.x
74. Reddy EC, Wang H, Bang KWA, Packham MA, Rand ML. Young steady-state rabbit platelets do not have an enhanced capacity to expose procoagulant phosphatidylserine. Platelets (2017):1-7. doi:10.1080/09537104.2017.1295434
75. Baaten CC, Veenstra LF, Wetzels R, van Geffen JP, Swieringa F, de Witt SM, et al. Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication. Haematologica (2015) 100(9):1131-8. doi:10.3324/haematol.2014.122457
76. Takubo T, Yamane T, Hino M, Ohta K, Koh KR, Tatsumi N. Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura. Haematologia (2000) 30(3):183-92. doi:10.1163/156855900300109189
77. Salvagno GL, Montagnana M, Degan M, Marradi PL, Ricetti MM, Riolfi P, et al. Evaluation of platelet turnover by flow cytometry. Platelets (2006) 17(3):170-7. doi:10.1080/09537100500437851
78. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol (2008) 52(9):743-9. doi:10.1016/j.jacc.2008.05.031
79. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood (2000) 95(5):1694-702
80. Prodan CI, Joseph PM, Vincent AS, Dale GL. Coated-platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors. J Thromb Haemost (2007) 5(10):2149-51. doi:10.1111/j.1538-7836.2007.02691.x
81. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature (2002) 415(6868):175-9. doi:10.1038/415175a
82. Heemskerk JW, Vuist WM, Feijge MA, Reutelingsperger CP, Lindhout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood (1997) 90(7):2615-25
83. Choo HJ, Kholmukhamedov A, Zhou C, Jobe S. Inner mitochondrial membrane disruption links apoptotic and agonist-initiated phosphatidylserine externalization in platelets. Arterioscler Thromb Vasc Biol (2017) 37(8):1503-12. doi:10.1161/ATVBAHA.117.309473
84. Wolf BB, Goldstein JC, Stennicke HR, Beere H, Amarante-Mendes GP, Salvesen GS, et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood (1999) 94(5):1683-92
85. Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Yao Y, Mason KD, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood (2009) 114(3):663-6. doi:10.1182/blood-2009-01-200345
86. Jackson SP, Schoenwaelder SM. Procoagulant platelets: are they necrotic? Blood (2010) 116(12):2011-8. doi:10.1182/blood-2010-01-261669
87. Mattheij NJ, Swieringa F, Mastenbroek TG, Berny-Lang MA, May F, Baaten CC, et al. Coated platelets function in platelet-dependent fibrin formation via integrin alphaIIbbeta3 and transglutaminase factor XIII. Haematologica (2016) 101(4):427-36. doi:10.3324/haematol.2015.131441
88. Keuren JF, Wielders SJ, Ulrichts H, Hackeng T, Heemskerk JW, Deckmyn H, et al. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol (2005) 25(7):1499-505. doi:10.1161/01.ATV.0000167526.31611.f6
89. Alberio L, Ravanat C, Hechler B, Mangin PH, Lanza F, Gachet C. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation. Thromb Haemost (2017) 117(6):1101-14. doi:10.1160/TH16-09-0711
90. Topalov NN, Kotova YN, Vasil'ev SA, Panteleev MA. Identification of signal transduction pathways involved in the formation of platelet subpopulations upon activation. Br J Haematol (2012) 157(1):105-15. doi:10.1111/j.1365-2141.2011.09021.x
91. Mattheij NJ, Gilio K, van Kruchten R, Jobe SM, Wieschhaus AJ, Chishti AH, et al. Dual mechanism of integrin alphaIIbbeta3 closure in procoagulant platelets. J Biol Chem (2013) 288(19):13325-36. doi:10.1074/jbc.M112.428359
92. Szasz R, Dale GL. Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets. Blood (2002) 100(8):2827-31. doi:10.1182/blood-2002-02-0354
93. Munnix IC, Cosemans JM, Auger JM, Heemskerk JW. Platelet response heterogeneity in thrombus formation. Thromb Haemost (2009) 102(6):1149-56. doi:10.1160/TH09-05-0289
94. Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med (2005) 15(3):86-92. doi:10.1016/j.tcm.2005.03.003
95. Munnix IC, Kuijpers MJ, Auger J, Thomassen CM, Panizzi P, van Zandvoort MA, et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol (2007) 27(11):2484-90. doi:10.1161/ATVBAHA.107.151100
96. Abaeva AA, Canault M, Kotova YN, Obydennyy SI, Yakimenko AO, Podoplelova NA, et al. Procoagulant platelets form an alpha-granule protein-covered "cap" on their surface that promotes their attachment to aggregates. J Biol Chem (2013) 288(41):29621-32. doi:10.1074/jbc.M113.474163
97. Mustard JF, Rowsell HC, Murphy EA. Platelet economy (platelet survival and turnover). Br J Haematol (1966) 12(1):1-24. doi:10.1111/j.1365-2141.1966.tb00121.x
98. Najean Y, Ardaillou N, Dresch C. Platelet lifespan. Annu Rev Med (1969) 20:47-62. doi:10.1146/annurev.me.20.020169.000403
99. Grozovsky R, Giannini S, Falet H, Hoffmeister KM. Novel mechanisms of platelet clearance and thrombopoietin regulation. Curr Opin Hematol (2015) 22(5):445-51. doi:10.1097/MOH.0000000000000170
100. Grozovsky R, Begonja AJ, Liu K, Visner G, Hartwig JH, Falet H, et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med (2015) 21(1):47-54. doi:10.1038/nm.3770
101. Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sorensen AL, Larson G, et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med (2009) 15(11):1273-80. doi:10.1038/nm.2030
102. Grewal PK, Aziz PV, Uchiyama S, Rubio GR, Lardone RD, Le D, et al. Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor. Proc Natl Acad Sci U S A (2013) 110(50):20218-23. doi:10.1073/pnas.1313905110
103. Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med (2008) 14(6):648-55. doi:10.1038/nm1760
104. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, et al. Programmed anuclear cell death delimits platelet life span. Cell (2007) 128(6):1173-86. doi:10.1016/j.cell.2007.01.037
105. Zhao L, Liu J, He C, Yan R, Zhou K, Cui Q, et al. Protein kinase A determines platelet life span and survival by regulating apoptosis. J Clin Invest (2017) 127(12):4338-51. doi:10.1172/JCI95109
106. Curtis BR, McFarland JG. Human platelet antigens-2013. Vox Sang (2014) 106(2):93-102. doi:10.1111/vox.12085
107. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood (1998) 92(11):4446-52
108. Alberio L. Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice. Hamostaseologie (2016) 36(4):227-40. doi:10.5482/HAMO-14-11-0074
109. Heuft HG, Moog R, Fischer EG, Zingsem J. German, Austrian Plateletpheresis Study G. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial. Transfusion (2013) 53(1):211-20. doi:10.1111/j.1537-2995.2012.03714.x
110. Gebhard S, Steil L, Peters B, Gesell-Salazar M, Hammer E, Kuttler B, et al. Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome. J Hypertens (2011) 29(11):2126-37. doi:10.1097/HJH.0b013e32834b1991
111. Heddle NM, Arnold DM, Acker JP, Liu Y, Barty RL, Eikelboom JW, et al. Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. Lancet Haematol (2016) 3(5):e246-54. doi:10.1016/S2352-3026(16)00020-X